be
2024: Technology Breakthrough Period (High-end Customization + Global Layout)​

2024: Technology Breakthrough Period (High-end Customization + Global Layout)​

1. Strategic Cooperation Achievements
Signed a Supply Agreement for High-end Peptide Intermediates with Pfizer Inc. (USA): Provided Fmoc-protected amino acids and peptide coupling intermediates for Pfizer's oncology drug production, with an annual supply volume of 1,500 tons and a contract value of 42 million US dollars. Becoming Pfizer's sole Asian supplier for this high-value category, the company's products meet USP Class 1 standards with peptide purity ≥ 99.9% and water content .2%, breaking the European and American monopoly.
Co-built a Pharmaceutical Intermediate R&D & Production Base in Singapore: Jointly invested 250 million US dollars with Singapore's Temasek Holdings to construct a 15,000-ton/year custom synthesis plant. Focusing on advanced intermediates for biologics and specialty drugs, the base will provide one-stop customization services for global pharmaceutical companies, with an expected annual sales volume exceeding 280 million US dollars after commissioning.


2. Export Scale Cases
Explosive Growth in Special Heterocyclic Intermediates Exports: Exported imidazole, pyrimidine and triazine derivatives to the EU, the Middle East and Japan, with an annual export volume of 10,000 tons and an export value of 280 million RMB, a year-on-year increase of 58%. The products meet ICH Q7 guidelines, accounting for 9% of Germany's specialty pharmaceutical intermediate market.
Full-scale Expansion in Latin American and Caribbean Markets: Exported beta-lactam intermediates and steroid intermediates to Brazil, Mexico, Cuba and other countries, with an annual export volume of 15,000 tons and an export value of 190 million RMB, a year-on-year growth of 68%. Among them, the market share in Brazil's API intermediate sector increased to 13%.


3. Market Breakthrough Cases
Breakthrough in North American Biopharmaceutical Intermediates: PEGylated intermediates (polyethylene glycol derivatives) obtained U.S. FDA DMF (Drug Master File) registration, entering the U.S. biologic drug production market with an annual export volume of 700 tons. The company became the only mainland Chinese supplier accessing North America's high-end biopharmaceutical intermediate market.
Upgraded Localized Technical Services in Europe: Established a technical support center in Frankfurt, Germany, providing process optimization, impurity control and regulatory compliance solutions for European pharmaceutical companies. This drove annual sales in the region to 85 million RMB with a customer repurchase rate of 94%.



Glutathione Gains Global Attention as Science, Wellness, and Regulation Converge
Dec 30, 25
Glutathione Gains Global Attention as Science, Wellness, and Regulation Converge

Glutathione, often referred to as the body’s “master antioxidant,” has moved from relative obscurity in medical textbooks to the center of global discussion in health, wellness, and biotechnology. Once known primarily to researchers and clinicians, this naturally occurring molecule is now widely discussed in contexts ranging from chronic disease research to skincare trends and dietary supplements. As interest continues to grow, scientists, regulators, and consumers alike are reexamining what glutathione is, what it can do, and how it should be used responsibly.

Dianabol (Methandienone) Remains at the Center of Global Debate on Performance-Enhancing Drugs
Oct 17, 25
Dianabol (Methandienone) Remains at the Center of Global Debate on Performance-Enhancing Drugs

With the deepening implementation of the "Made in China 2025" strategy and the rapid advancement of high-end equipment manufacturing, China's coupling industry is accelerating its transformation toward intelligent and precision-oriented development. 

Growing Concerns Surround the Illicit Market for Anabolic Steroids Oil Dianabol
Oct 17, 25
Growing Concerns Surround the Illicit Market for Anabolic Steroids Oil Dianabol

The global conversation around performance-enhancing drugs has intensified once again as anabolic steroids, particularly products marketed as Oil Dianabol, continue to surface in illegal markets. Dianabol, scientifically known as methandrostenolone, is one of the most well-known anabolic steroids in bodybuilding history. Originally developed in the mid-20th century for medical use, it has long since become controversial due to widespread misuse, health risks, and regulatory crackdowns.

Contact Us
Contact Us Let's TalkYour Any Query
Subscribe For Newsletter!
Your Email...

If you are interested in our products, you can choose to leave your information here, and we will be in touch with you shortly.